Open original FDA record ↗Recall record
- FDA identifier
- Z-0191-2027
- Company in FDA record
- Abbott
- FDA classification date
- Oct 16, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Changes to Instructions for Use (IFU) for the device regarding risk of Pulmonary Artery Injury (PAI).
Source facts
- Action
- US IFU was updated and is available via https://manuals.eifu.abbott as of September 4, 2026. The firm began notifying consignees of the updated IFU on September 10, 2026. Abbott asks that physician users continue to follow all procedural steps that have already been provided via training, and that are now included in the IFU, as presented below: " After the landing zone has been identified, assess the closest distance to the pulmonary artery. " A distance =1.5 mm represents significant risk for a pulmonary artery injury; a distance between 1.5 and 3.0 mm represents a theoretical risk for a pulmonary artery injury; and a distance >3.0 mm represents a lower risk for a pulmonary artery injury. " To reduce the risk of pulmonary artery injury, consider an alternative landing zone or device orientation when clinically appropriate and C.L.O.S.E. criteria can still be met. " If the risk of pulmonary artery injury cannot be adequately minimized, the physician should carefully consider whether to proceed with device implantation.
- Initiated
- 2026-09-10
- Root cause
- Labeling design
- Distribution
- Worldwide - US Nationwide distribution.
- Recall number
- Z-0191-2027
- Recall status
- Open, Classified
- CDRH record ID
- 222724
- FDA classified
- 2026-10-16
- Recall event number
- 99844